Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
46.35    1.10 (2.43%)
Bid:
46.35
Ask:
46.65
Spread: 0.30 (0.647%)
Market Cap: £293.33m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Interim Management Statement

25 Jul 2012 07:00

RNS Number : 4138I
Marston's PLC
25 July 2012
Β 

ο»Ώ

Β 

MARSTON'S PLC

INTERIM MANAGEMENT STATEMENT

42 weeks to 21 July 2012

Β 

Β 

Trading

Our performance has been satisfactory in recent weeks in view of the very wet weather conditions affecting summer trading to date. We have continued to make progress across the business, with profitability in line with our expectations.

Β 

In managed pubs, like-for-like sales for the 42 week period were 2.2% ahead of last year, including like-for-like food sales growth of 2.4% and like-for-like wet sales growth of 2.1%. In the 10 week period since 12 May, like-for-like sales increased by 1.6%. Operating margin is slightly above last year, and we remain on track to complete 25 of our high return new-build pub restaurants in the current financial year.

Β 

In our tenanted and franchised pubs underlying trends have continued to improve with operating profit estimated to be 3.2% ahead of last year. This reflects a strong performance in the franchise estate, which now operates in around 450 pubs, and continued stability and modest growth in the traditional tenanted and leased estate.

Β 

In brewing, we have continued to increase market share with own-brewed beer volumes up around 2% versus last year.

Β 

Net debt and cash flow are in line with expectations.

Commenting, Ralph Findlay, Chief Executive Officer said:

"Our performance to date demonstrates that our focus on offering great value for money underpinned by high service levels remains attractive to our customers despite the wider economic challenges. In recent weeks we have achieved sales growth despite the poor weather, helped by key trading events including the Jubilee weekend, Euro 2012 and Father's Day. By the end of this financial year we will have built around 60 new pub-restaurants in three years, and we have a clear site pipeline for future development."

Β 

Forthcoming Events

Please find below the forthcoming reporting dates for the Group, which are also available on the investor calendar on our website, www.marstons.co.uk/investors

Β 

Year end trading statement

3 October 2012

2012 Preliminary results

29 November 2012

2013 Interim Results

16 May 2013

2013 Preliminary results

28 November 2013

Β 

The financial year 2013 will be a 53 week period ending 5 October 2013.

Β 

ENQUIRIES:

Marston's PLC

HudsonΒ Sandler

Ralph Findlay, Chief Executive Officer

Andrew Hayes / Andrew Leach / George Parker

Andrew Andrea, Chief Financial Officer

Tel: 01902 329516

Tel: 020 7796 4133

Β 

NOTES TO EDITORS

β—‹

Marston's is a leading pub operator and independent brewer.

β—‹

It has an estate of around 2,150 pubs situated nationally; comprising tenanted, leased, franchised and managed pubs.

β—‹

It is the UK's leading brewer of premium cask and bottled ales, including Marston's Pedigree and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers.

β—‹

Marston's employs over 12,000 people throughout England and Wales.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSUSUNRUWABUAR
Date   Source Headline
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector Declaration
18th Dec 20194:28 pmRNSAnnual Financial Report
12th Dec 20193:52 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSPreliminary Results
25th Nov 20197:00 amRNSCompletion of Disposal
21st Nov 20192:52 pmRNSDirectorate Change
4th Nov 20197:00 amRNSDisposal
1st Nov 20192:24 pmRNSTotal Voting Rights
15th Oct 20197:00 amRNSYear End Trading Update
1st Oct 201910:05 amRNSTotal Voting Rights
2nd Sep 20192:15 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSBoard Changes
24th Jul 20197:00 amRNSTrading Update
10th Jul 201911:15 amRNSBlock listing Interim Review
17th Jun 20193:37 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSInterim results for 26 weeks ended 30 March 2019
4th Mar 201911:51 amRNSTotal Voting Rights
1st Feb 20199:11 amRNSTotal Voting Rights
24th Jan 201910:29 amRNSResult of AGM
23rd Jan 20197:00 amRNSTrading Update for the 16 weeks to 19 January 2019
11th Jan 20198:48 amRNSBlock listing Interim Review
2nd Jan 20192:20 pmRNSTotal Voting Rights
19th Dec 201811:04 amRNSAnnual Financial Report
13th Dec 20183:09 pmRNSDirector/PDMR Shareholding
13th Dec 20183:07 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSPreliminary Results
8th Nov 20188:46 amRNSHolding(s) in Company
6th Nov 20184:19 pmRNSHolding(s) in Company
2nd Nov 20182:39 pmRNSHolding(s) in Company
1st Nov 20183:35 pmRNSHolding(s) in Company
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company
10th Oct 20187:00 amRNSYEAR END TRADING UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.